Venture Capital

Enodia Therapeutics: €20.7 Million Seed Funding Closed To Advance SEC61-Based Small-Molecule Protein Degradation Platform

By Amit Chowdhry ● Jan 10, 2026

Enodia Therapeutics has raised €20.7 million (about $25 million) in a seed financing to advance a discovery platform that uses proteomics and machine learning to develop small molecules that degrade disease-driving proteins at the point of synthesis. The round was co-led by Elaia, Pfizer Ventures, and Bpifrance as part of its InnoBio investment strategy, with participation from Wallonie Entreprendre, Argobio Studio, MACSF, The Institut Pasteur, InvestSud, Sambrinvest, and Mission BioCapital.

SonoThera: $125 Million Series B Raised To Advance Ultrasound-Mediated Genetic Medicines Toward First-In-Human Trials

By Amit Chowdhry ● Jan 10, 2026

SonoThera announced it will officially launch a $125 million Series B funding round at the 44th annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026, as the company looks to advance multiple genetic medicine programs toward first-in-human studies.

Engitix: $25 Million Series A Extension Closed To Advance ECM-Targeted Pipeline In Oncology and Fibrosis

By Amit Chowdhry ● Jan 9, 2026

Engitix Therapeutics announced it has closed a $25 million Series A extension financing led by Netherton Investments, a fund investing on behalf of Mike Platt, co-founder and managing director of BlueCrest Capital Management.

Argobio Launches Enodia With €20.7 Million Seed Round To Develop Small Molecules For Protein Degradation

By Amit Chowdhry ● Jan 9, 2026

Argobio Studio announced it has launched Enodia Therapeutics and completed a €20.7 million ($25 million) seed financing to advance a small-molecule platform for targeted protein degradation at the point of protein synthesis, enabled by proteomics and machine learning.

Truelink Capital To Invest In Prime Electric

By Amit Chowdhry ● Jan 9, 2026

Truelink Capital announced it has signed a definitive agreement to make a significant investment in Prime Electric, a Bellevue, Washington-based provider of electrical system repair, installation and maintenance services. Financial terms were not disclosed.

Verana Health: $52 Million Raised And Merger With COTA

By Amit Chowdhry ● Jan 9, 2026

Verana Health announced it has merged with COTA, combining real-world data (RWD) assets and AI-driven curation technology to expand the scale and clinical depth of its offerings for biopharma customers across oncology and other specialties.

Broadview Group Invests In Citadel EHS

By Amit Chowdhry ● Jan 9, 2026

Broadview Group, a St. Louis-based private investment firm, announced it has invested Citadel EHS, an environmental, health, safety, and sustainability (EHS&S) consulting provider.

Lights Out Sports Sells Controlling Stake To A.R.I., Names Zack Ellison Chairman And CEO

By Amit Chowdhry ● Jan 9, 2026

Lights Out Sports said Applied Real Intelligence (A.R.I.) has acquired a controlling majority interest in the combat-sports and media platform, adding an expanded governance role as the company looks to scale across live events, streaming distribution, and brand partnerships.

Warburg Pincus Closes $3 Billion Financial Sector Fund III

By Amit Chowdhry ● Jan 9, 2026

Warburg Pincus announced it has closed Warburg Pincus Financial Sector III (WPFS III) with $3.0 billion of capital commitments, exceeding the fund’s initial $2.5 billion target. The firm said WPFS III launched in 2024 and is its largest financial services-focused fund to date.

MidEuropa Buys Majority Stake In Romanian Business Consult

By Amit Chowdhry ● Jan 9, 2026

MidEuropa, a private equity firm focused on Central Europe, announced it has agreed to acquire a majority stake in Romanian Business Consult (RBC), an IT system integrator serving the retail, banking, and industrial sectors in Romania.

Haveli Investments To Take Majority Stake In Sirion

By Amit Chowdhry ● Jan 9, 2026

Sirion, a contract lifecycle management (CLM) software provider, announced it has signed a definitive agreement for Haveli Investments, an Austin-based technology-focused investment firm, to make a majority investment in the company.

KAHR Bio: $22 Million Raised And Phase 2 Topline Data For DSP107 Combo In MSS Colorectal Cancer

By Amit Chowdhry ● Jan 9, 2026

KAHR Bio announced it posted “strong” topline results from a Phase 2a dose-expansion cohort evaluating its investigational immunotherapy DSP107 in combination with Roche’s atezolizumab (Tecentriq) in late-line metastatic microsatellite stable colorectal cancer (MSS-CRC), a setting where checkpoint inhibitors have historically shown limited benefit.

Pomelo Care: $92 Million Series C At $1.7B Valuation Closed To Expand Beyond Maternity

By Amit Chowdhry ● Jan 9, 2026

Pomelo Care announced it raised $92 million in Series C funding at a $1.7 billion valuation as it moves to broaden its virtual, evidence-based care model beyond maternity into a wider set of women’s and children’s health needs across the lifespan.

Davidson Kempner Closes $1.1+ Billion Income Fund II For Global Asset-Backed Private Credit Strategy

By Amit Chowdhry ● Jan 9, 2026

Davidson Kempner Capital Management announced it has reached a final close for Davidson Kempner Income Fund II, raising aggregate capital commitments to the firm’s global asset-backed private credit strategy, including related separate accounts, to more than $1.1 billion. The firm said the second vintage in the series exceeded its fundraising target.

Flywheel Raises $27.5 Million And Expands Clinical Trial And Medical Device Offerings

By Amit Chowdhry ● Jan 9, 2026

Flywheel, a medical imaging data management and analysis platform, reported record momentum in 2025, launched new products aimed at clinical trial and medical device workflows, and disclosed the close of a $27.5 million equity financing round.

Valinor Enterprises: $54 Million Series A Raised To Expand Defense-Tech Holding Company Model

By Amit Chowdhry ● Jan 9, 2026

Valinor Enterprises, an operational holding company focused on defense and government technology, said it raised $54 million in Series A financing, bringing total capital raised to more than $85 million. The round was led by Friends & Family Capital, a venture firm co-founded by former Palantir CFO Colin Anderson and investor John Fogelsong. Existing backers General Catalyst, Founders Fund, and Red Cell Partners also participated, while new investors included Narya, XYZ Venture Capital, and Fifth Down Capital.

AgileRL Raises Seed Round To Launch Arena RLOps Platform In The U.S.

By Amit Chowdhry ● Jan 8, 2026

AgileRL has raised a seed financing round backed by Fusion Fund and Flying Fish, with participation from existing investors Octopus Ventures and Counterview Capital, bringing the company’s total funding raised to $7.5 million.

Prudentia Sciences: $20 Million Series A Raised To Speed Life Sciences Deal Diligence

By Amit Chowdhry ● Jan 8, 2026

Prudentia Sciences announced it raised $20 million in Series A financing to expand its AI-native due diligence platform for life sciences dealmaking, aiming to help pharmaceutical companies, biotechs, and financial institutions evaluate therapeutic assets faster and with more rigor.

Luminate: $21 Million Series A Extension Closed To Scale At-Home Cancer Infusions And Patient-Led Delivery Technology

By Amit Chowdhry ● Jan 8, 2026

Luminate, a Galway, Ireland-based healthcare technology company focused on delivering cancer therapies in the home, has raised $21 million in an expanded Series A round, bringing total funding to more than $50 million. The round was co-led by ARTIS Ventures and Lachy Groom, with participation from Western Alliance Life Sciences and existing backers including 8VC, Y Combinator, Atlantic Bridge, Faber, SciFounders, and others. The company said the financing follows growing interest from health systems in its Lotus program for home-based cancer care.

Redgate Software Secures Growth Investment From Bregal Sagemount

By Amit Chowdhry ● Jan 8, 2026

Redgate Software announced it has received a strategic growth investment from Bregal Sagemount, a growth-focused private equity firm, in a transaction that will make Sagemount the majority shareholder of Redgate, pending regulatory approvals and customary closing conditions. Financial terms were not disclosed, and the companies said the deal is expected to close in late Q1 2026.

Adams Street Partners Closes $350 Million Debut Public CLO For Middle-Market Direct Lending Portfolio

By Amit Chowdhry ● Jan 8, 2026

Adams Street Partners’ private credit team has held the final close of a $350 million middle-market collateralized loan obligation, ASP PIF CLO I, LLC, marking the firm’s inaugural public CLO issuance. The firm said the deal expands its private credit financing toolkit and brings in third-party capital to support the continued growth of its direct lending platform.

Catalio Closes Structured Opportunities Fund II With Over $325 Million For Healthcare Structured Credit

By Amit Chowdhry ● Jan 8, 2026

Catalio Capital Management announced it has closed its second credit fund, Catalio Structured Opportunities Fund II, with more than $325 million in commitments across the fund and related co-investment vehicles, exceeding its fundraising target and signaling continued investor demand for non-dilutive financing options in healthcare.

ATG Emerges From Stealth With $15 Million To Build An AI-Based Financial Advisor

By Amit Chowdhry ● Jan 8, 2026

Autonomous Technologies Group (ATG) announced it has emerged from stealth as an AI research lab focused on building an advanced AI financial advisor, positioning its flagship product, Autonomous, as a personalized investment strategist that combines market data, portfolio theory, behavioral finance, and user context to guide investment decisions.

Poplar Therapeutics Launched With $50 Million Series A To Advance Anti-IgE Therapy for Multiple Atopic Conditions

By Amit Chowdhry ● Jan 8, 2026

Poplar Therapeutics has launched as a clinical-stage immunology company with a $50 million Series A financing to advance PHB-050, a next-generation anti-IgE antibody being developed for food allergy and other atopic conditions such as asthma and atopic dermatitis.

Adapture Renewables: $233 Million U.S. Bank Tax Equity Commitment Secured For Titanium Solar Projects

By Amit Chowdhry ● Jan 8, 2026

Adapture Renewables announced it has closed $233 million in tax equity financing commitments from U.S. Bank to support two solar projects in its Titanium portfolio, advancing the multi-site development toward construction completion and commercial operation.

IMVARIA Announces Strategic Investments For AI-Based Digital Biomarker Solutions

By Amit Chowdhry ● Jan 8, 2026

IMVARIA, a Berkeley, California-based health tech company developing AI-driven digital biomarker solutions, said it has secured strategic investments from new and existing investors to accelerate growth and expand its AI-powered diagnostic services.

Blackstone Buys Madison Dearborn’s Remaining Stake In AIR

By Amit Chowdhry ● Jan 8, 2026

Blackstone announced that funds managed by its private equity strategy for individual investors have acquired Madison Dearborn Partners’ remaining equity stake in AIR Control Concepts (AIR), increasing Blackstone’s ownership following its original investment in July 2024. Founder, President and CEO Brad Hobbs and his family will also invest alongside Blackstone, and the transaction makes Blackstone AIR’s sole institutional investor.

Corsera Health: $80 Million Series A Raised To Advance Cardiovascular Disease Prediction

By Amit Chowdhry ● Jan 8, 2026

Corsera Health announced it raised an oversubscribed $80 million Series A to advance its cardiovascular disease prediction-and-prevention strategy and to fund development of once-annual preventive RNAi medicines targeting the two primary drivers of atherosclerotic cardiovascular disease (ASCVD): elevated LDL cholesterol and high blood pressure. The round was co-led by Forbion and Population Health Partners, with participation from additional investors including Corsera co-founder and co-CEO John Maraganore, Ph.D. As part of the financing, Forbion general partner Marco Boorsma, Ph.D., will join Corsera’s board.

Nocion Therapeutics: $93 Million Series B Closed To Advance Taplucainium Toward Late-Stage Development In Chronic Cough

By Amit Chowdhry ● Jan 8, 2026

Nocion Therapeutics announced it has raised $23 million from existing investors in an extension of its Series B financing, bringing the total Series B proceeds to $93 million as the company advances taplucainium, its investigational inhaled therapy for refractory or unexplained chronic cough.

Soley Therapeutics: $200 Million Series C Closed To Advance Oncology Assets Into the Clinic

By Amit Chowdhry ● Jan 8, 2026

Soley Therapeutics has raised $200 million in Series C funding to move its cell stress-sensing platform and pipeline into clinical development, including IND-enabling work and trials for two first-in-class, internally discovered oncology programs. The company said proceeds will also support the advancement of non-oncology stress-reducing drug candidates targeting neurodegenerative disorders and metabolic diseases, as well as continued platform scale-up.